Navigation Links
Lead Removing Drug Improves Muscle Function in Lead-Exposed Children

Researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural// balance and movement in lead-exposed children.

Led by Amit Bhattacharya, PhD, the UC team found that children treated with succimer (SUX-sim-er) chelation therapy showed a 19 percent improvement in their ability to perform moving tasks—such as crossing an obstacle or walking—than those who did not receive treatment.

Chelation (ke-LAY-shun) is a technique, nicknamed “scrubbing,” in which a drug is administered to seek out and bind to poisonous heavy metals, such as lead or mercury, in the bloodstream. The compound resulting from this binding is then excreted in the urine, essentially cleaning out the dangerous metals.

Succimer (Chermet) is an oral chelating drug approved by the Food and Drug Administration to treat children with extremely elevated blood lead levels (44 to 69 micrograms per deciliter).

The UC team has found that succimer chelation therapy improved static balance by 6 percent.

“Lead exposure is a very serious issue,” says Bhattacharya, professor of environmental health and lead author of the study, “and it’s important to identify early signs of neuromotor (muscle-function) exposure effects—such as impaired postural balance or locomotion—before permanent damage occurs. Our research may help develop control strategies for minimizing exposure to lead at an earlier stage.”

The team reports its findings in the May 2007 edition of the journal Neurotoxicology. This is the first study to report that succimer chelation therapy can produce beneficial effects on postural balance and movement in lead-exposed children.

Previous research has shown that succimer chelation therapy can reduce lead levels in the blood, but few scientists have investigated whether it can improve neuromotor abilities in this at-risk population.

Bhattacharya and his team wanted to know if succimer chelation therapy could eliminate or minimize lead-associated muscle-function impairments in children exposed to high levels of lead early in life.

The team identified about 160 Cincinnati children with elevated blood lead levels enrolled in the local arm of a randomized, placebo-controlled clinical trial conducted nationally by the Centers for Disease Control and Prevention and the National Institute of Environmental Health Sciences (NIEHS). Postural balance and gait tests were performed only after each child—then 5 years old—had completed the succimer or placebo therapy.

Tests were designed to eliminate or challenge factors that help maintain postural balance, such as eyesight and visual context.

“Our statistical analysis revealed that subjects who received succimer therapy showed a significant improvement in balance and movement compared to the non-therapy group,” says Bhattacharya. “This new data—combined with our previous research—leads us to believe that succimer therapy may also result in reduced injuries among this at-risk population.”

In the October 2006 issue of the Journal of Adolescent Health, Bhattacharya’s team reported that teenagers who experienced high blood lead levels during childhood appear to suffer more accidental injuries than those who had lower lead exposure.

He says further research is needed to determine if succimer therapy can minimize long-term negative effects of lead on balance and movement.

According to the most recent U.S. National Health and Nutrition Examination Survey, more than 434,000 children between the ages of 1 and 5 have elevated blood lead levels. Lead is known to be associated with decreased intellectual capabilities and balance disorders among infants, children and teens.

Source-urekalert
SRM/B
'"/>




Related medicine news :

1. Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts
2. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
3. Sage Improves Memory
4. Combination Therapy Found To Improves Stroke Recovery
5. Caffeine Boosts Memory, Improves Attention Span
6. Children’s Health Improves By Swimmin
7. Fetal Neural Grafts Improves Motor and Cognitive Function in Huntington Patients
8. Folic Acid Improves Survival Rate Of Children With Birth Defects
9. Drug Combo Improves Performance Of Multiple Sclerosis Drug
10. Weight Training Improves Quality Of Life In Breast Cancer Patients
11. Ginseng Improves The Survival Rates Of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: